连接会议、学者、机构、期刊的产学研服务平台

会议目录会议库创建会议会议投稿联合办会

学者目录我的主页

机构目录创建机构

期刊目录期刊入驻期刊投稿创办期刊

产学研资讯发布供需

快速参会创建会议稿件处理

连接会议、学者、机构、期刊的产学研服务平台

平台入口

会议目录
学者目录
机构目录

功能入口

创建会议
创建机构
期刊入驻
个人中心

平台政策

服务条款
隐私政策
版权说明
联系我们

© 2026 微科研. 保留所有权利。

Stergios Boussios

Stergios Boussios

King's College London

学术指标

49

H 指数

研究方向

先进传感与能量采集材料

联系方式

cd****@cancerdrugresist.net

个人简介

Stergios Boussios，现任King's College London。主要从事先进传感与能量采集材料研究。

科研成果

175
论文成果: 5,875
总引用量

代表作品

优先展示有引用数据的代表论文。

高引文章

按引用次数从高到低排列。

1
Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review
Critical Reviews in Oncology/Hematology2016被引 179
2
HPV and Cervical Cancer: A Review of Epidemiology and Screening Uptake in the UK
Pathogens2023被引 170
3
The Developing Story of Predictive Biomarkers in Colorectal Cancer
Journal of Personalized Medicine2019被引 169
4
Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management.
PubMed2012被引 169
5
Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond
Drugs in R&D2020被引 142
6
Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature Review
Diagnostics2019被引 127
7
Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4
Therapeutic Advances in Medical Oncology2024被引 125
8
Applications of Proteomics in Ovarian Cancer: Dawn of a New Era
Proteomes2022被引 121
9
Recent Insights into PARP and Immuno-Checkpoint Inhibitors in Epithelial Ovarian Cancer
International Journal of Environmental Research and Public Health2022被引 113
10
BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside
Cancers2022被引 112
11
Advances in Ovarian Cancer Treatment Beyond PARP Inhibitors
2023被引 103
12
BRCA Mutations in Prostate Cancer: Assessment, Implications and Treatment Considerations
2021被引 102
13
First-Line Maintenance Therapy Patterns in BRCA Wild-Type, HRD-Negative or Biomarker-Unknown Advanced Epithelial Ovarian Cancer: A Five-Country European Real-World Study by APLUSA
ORCID2026
14
Incorporating Metastatic Disease Burden into Prognostic Assessment in Metastatic Castration-Resistant Prostate Cancer: The MIRA Score
ORCID2026
15
Wearable Devices and Machine Learning in Cardiovascular Monitoring: Current Evidence and Future Directions for Precision Medicine
ORCID2026
16
First-line maintenance therapy patterns in BRCA wild-type and HRD-negative advanced epithelial ovarian cancer: A European real-world study.
ORCID2026
17
On-treatment serum prostate-specific antigen and overall survival in prostate cancer (STAMPEDE platform protocol): a post-hoc analysis of data from five phase 3 trials
ORCID2026
18
Eprenetapopt in combination with carboplatin in high-grade ovarian and triple negative breast cancer cell lines with acquired resistance to olaparib
ORCID2026
19
The Current Landscape of Artificial Intelligence in Positron Emission Tomography (PET) Imaging Across the Cancer Continuum
ORCID2026
20
Genetically Optimized Modular Neural Networks for Precision Lung Cancer Diagnosis: Exploratory Study of Novel Approach
ORCID2026

最后更新： 2026/9/28 14:39:48